Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.
- DOI
- 10.1136/jitc-2026-015273
- Published
- 2026-07-24
- Container
- J Immunother Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2026-015273,
title = {Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.},
author = {Tougeron D and Kauffmann C and Ambrosini M and Boussari O and Lonardi S and Sinicrope FA and Fakih M and Overman MJ and Elez E and Turpin A and Decraecker M and Hollebecque A and Pernot S and Mazard T and Dutherage M and Cohen R and Sclafani F and Ben Abdelghani M and Aparicio T and Coutzac C and Hautefeuille V and Muller M and Cremolini C and Guimbaud R and Taieb J and Pietrantonio F and Olivier R and Alouani E.},
year = {2026},
journal = {J Immunother Cancer},
doi = {10.1136/jitc-2026-015273},
url = {https://doi.org/10.1136/jitc-2026-015273}
}RIS
TY - JOUR TI - Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy. AU - Tougeron D AU - Kauffmann C AU - Ambrosini M AU - Boussari O AU - Lonardi S AU - Sinicrope FA AU - Fakih M AU - Overman MJ AU - Elez E AU - Turpin A AU - Decraecker M AU - Hollebecque A AU - Pernot S AU - Mazard T AU - Dutherage M AU - Cohen R AU - Sclafani F AU - Ben Abdelghani M AU - Aparicio T AU - Coutzac C AU - Hautefeuille V AU - Muller M AU - Cremolini C AU - Guimbaud R AU - Taieb J AU - Pietrantonio F AU - Olivier R AU - Alouani E. PY - 2026 JO - J Immunother Cancer DO - 10.1136/jitc-2026-015273 UR - https://doi.org/10.1136/jitc-2026-015273 ER -
APA
D, T., C, K., M, A., O, B., S, L., FA, S., M, F., MJ, O., E, E., A, T., M, D., A, H., S, P., T, M., M, D., R, C., F, S., M, B. A., T, A., C, C., V, H., M, M., C, C., R, G., J, T., F, P., R, O., & E., A. (2026). Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.. J Immunother Cancer. https://doi.org/10.1136/jitc-2026-015273
Source records
- europe-pmc · retrieved 2026-09-25T10:26:21.251Z